BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18164876)

  • 1. Expression of bioactive porcine interferon-gamma by recombinant Lactococcus lactis.
    Rupa P; Monedero V; Wilkie BN
    Vet Microbiol; 2008 May; 129(1-2):197-202. PubMed ID: 18164876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of biological active murine IFN-gamma by recombinant Lactococcus lactis.
    Bermúdez-Humarán LG; Cortes-Perez NG; L'Haridon R; Langella P
    FEMS Microbiol Lett; 2008 Mar; 280(2):144-9. PubMed ID: 18248432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of biologically active porcine interleukin-2 by Lactococcus lactis.
    Avall-Jääskeläinen S; Palva A
    Vet Microbiol; 2006 Jun; 115(1-3):278-83. PubMed ID: 16549279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous protein production and delivery systems for Lactococcus lactis.
    Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
    Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of biologically active murine interleukin-18 in Lactococcus lactis.
    Feizollahzadeh S; Khanahmad H; Rahimmanesh I; Ganjalikhani-Hakemi M; Andalib A; Sanei MH; Rezaei A
    FEMS Microbiol Lett; 2016 Nov; 363(21):. PubMed ID: 27864297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nisin-controlled extracellular production of apidaecin in Lactococcus lactis.
    Zhou XX; Wang YB; Pan YJ; Li WF
    Appl Microbiol Biotechnol; 2008 Apr; 78(6):947-53. PubMed ID: 18286279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J; Medina M; Raya R; Alvarez S
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
    Shi D; Song Y; Li YJ
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant.
    Cortes-Perez NG; da Costa Medina LF; Lefèvre F; Langella P; Bermúdez-Humarán LG
    Vaccine; 2008 Oct; 26(46):5778-83. PubMed ID: 18790708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix.
    Kim TW; Igimi S; Kajikawa A; Kim HY
    J Appl Microbiol; 2008 Jun; 104(6):1636-43. PubMed ID: 18298534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of food-grade inducible expression system in Lactococcus lactis and expression of fusion OprF/H from Pseudomonas aeruginosa].
    Xu B; Cao YS; Chen Y; Guo XH
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):604-9. PubMed ID: 17944358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion of human interferon-beta 1b by recombinant Lactococcus lactis.
    Zhuang Z; Wu ZG; Chen M; Wang PG
    Biotechnol Lett; 2008 Oct; 30(10):1819-23. PubMed ID: 18575814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of divercin RV41 produced and secreted by Lactococcus lactis.
    Bermúdez-Humarán LG; Rihakova J; Langella P; Demnerova K; Nazef L; Prévost H; Drider D
    J Mol Microbiol Biotechnol; 2007; 13(4):259-63. PubMed ID: 17827978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion to a carrier protein and a synthetic propeptide enhances E7 HPV-16 production and secretion in Lactococcus lactis.
    Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Gruss A; Rodriguez-Padilla C; Saucedo-Cardenas O; Langella P; Montes de Oca-Luna R
    Biotechnol Prog; 2003; 19(3):1101-4. PubMed ID: 12790689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A xylose-inducible expression system for Lactococcus lactis.
    Miyoshi A; Jamet E; Commissaire J; Renault P; Langella P; Azevedo V
    FEMS Microbiol Lett; 2004 Oct; 239(2):205-12. PubMed ID: 15476967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination.
    Wang K; Huang L; Kong J; Zhang X
    J Virol Methods; 2008 Jun; 150(1-2):1-6. PubMed ID: 18406475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome analysis of lactic acid bacteria in food fermentations and biotechnological applications.
    Nga BH
    Curr Opin Microbiol; 2005 Jun; 8(3):307-12. PubMed ID: 15939354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A food-grade expression/secretion vector for Lactococcus lactis that uses an alpha-galactosidase gene as a selection marker.
    Jeong DW; Lee JH; Kim KH; Lee HJ
    Food Microbiol; 2006 Aug; 23(5):468-75. PubMed ID: 16943039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.
    Steidler L; Neirynck S; Huyghebaert N; Snoeck V; Vermeire A; Goddeeris B; Cox E; Remon JP; Remaut E
    Nat Biotechnol; 2003 Jul; 21(7):785-9. PubMed ID: 12808464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.